Plasma serotonin levels and the platelet serotonin transporter
Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT...
Saved in:
| Published in | Journal of neurochemistry Vol. 102; no. 1; pp. 206 - 215 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.07.2007
Blackwell Publishing Ltd Blackwell |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-3042 1471-4159 |
| DOI | 10.1111/j.1471-4159.2007.04542.x |
Cover
| Abstract | Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in Vmax with a similar Km; also, the decrease in Vmax was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT. |
|---|---|
| AbstractList | Serotonin (5HT) is a platelet‐stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in Vmax with a similar Km; also, the decrease in Vmax was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT. Serotonin (5HT) is a platelet‐stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in V max with a similar K m ; also, the decrease in V max was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT. Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in V sub(max) with a similar K sub(m); also, the decrease in V sub(max) was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT. Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in Vmax with a similar Km; also, the decrease in Vmax was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT.Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in Vmax with a similar Km; also, the decrease in Vmax was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT. Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including hypertension. The actions of 5HT are mediated by different types of receptors and terminated by a single 5HT transporter (SERT). Therefore, SERT is a major mechanism that regulates plasma 5HT levels to prevent vasoconstriction and thereby secure a stable blood flow. In this study, the response of platelet SERT to the plasma 5HT levels was examined within two models: (i) in subjects with chronic hypertension or normotension; (ii) on platelets isolated from normotensive subjects and pretreated with 5HT at various concentrations. The platelet 5HT uptake rates were lower during hypertension due to a decrease in V max with a similar K m; also, the decrease in V max was primarily due to a decrease in the density of SERT on the platelet membrane, with no change in whole cell expression. Additionally, while the platelet 5HT content decreased 33%, the plasma 5HT content increased 33%. Furthermore, exogenous 5HT altered the 5HT uptake rates by changing the density of SERT molecules on the plasma membrane in a biphasic manner. Therefore, we hypothesize that in a hypertensive state, the elevated plasma 5HT levels induces a loss in 5HT uptake function in platelets via a decrease in the density of SERT molecules on the plasma membrane. Through the feedback effect of this proposed mechanism, plasma 5HT controls its own concentration levels by modulating the uptake properties of platelet SERT. [PUBLICATION ABSTRACT] |
| Author | Mehta, J.L Ahmed, B.A Unal, R Brenner, B Jeffus, B.C Kilic, F Harney, J.T |
| AuthorAffiliation | Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA Department of Emergency Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA Department of Internal Medicine and Physiology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA |
| AuthorAffiliation_xml | – name: Department of Internal Medicine and Physiology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA – name: Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA – name: Department of Emergency Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA |
| Author_xml | – sequence: 1 fullname: Brenner, B – sequence: 2 fullname: Harney, J.T – sequence: 3 fullname: Ahmed, B.A – sequence: 4 fullname: Jeffus, B.C – sequence: 5 fullname: Unal, R – sequence: 6 fullname: Mehta, J.L – sequence: 7 fullname: Kilic, F |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18837878$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17506858$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl9v0zAUxS00xLrBV4AIib2lXMd27DwwCVX81QRIsGfLSW82V67d2enYvv0cWtrBy5YXR_LvnnvP9TkiBz54JKSgMKX5e7uYUi5pyalophWAnAIXvJrePCGT3cUBmQBUVcmAV4fkKKUFAK15TZ-RQyoF1EqoCTn94UxamiJhDEPw1hcOr9Glwvh5MVxisXJmQIfDPWKIxqdViAPG5-Rpb1zCF9vzmJx__PBr9rk8-_7py-z9WdnVjFZl39QMsW-RQ9N0bScYtj1AHkbxhvE8lgLMPiRtqGhlj5WSwNt5wykYzgQ7Jqcb3dW6XeK8Q5-HcHoV7dLEWx2M1f_eeHupL8K1zu6zOssCJ1uBGK7WmAa9tKlD54zHsE5aQk1ZLfmDIJdMCEHpg2AFua2kY-vX_4GLsI4-rysztRCg1Gjw5X2DO2d_XyoDb7aASZ1xfX6DzqY9pxSTSo6c2nBdDClF7PcI6DE8eqHHjOgxI3oMj_4THn2zX_KutLODGWwYV2rdYwTebQR-W4e3j26sv36bjX-5_tWmvjdBm4uY_Z3_rICyDCvGhGR3GdDk7Q |
| CODEN | JONRA9 |
| CitedBy_id | crossref_primary_10_1038_s41598_019_53312_0 crossref_primary_10_1371_journal_pone_0072580 crossref_primary_10_1016_j_mce_2014_06_006 crossref_primary_10_1016_j_physbeh_2019_02_017 crossref_primary_10_1038_s41598_018_21348_3 crossref_primary_10_1111_j_1471_4159_2008_05634_x crossref_primary_10_1007_s00210_011_0622_1 crossref_primary_10_1016_j_aquaculture_2020_735173 crossref_primary_10_1002_jez_2554 crossref_primary_10_1080_09553002_2020_1704911 crossref_primary_10_1007_s11055_015_0147_z crossref_primary_10_1155_2019_3546294 crossref_primary_10_1016_j_cellsig_2015_03_013 crossref_primary_10_14202_vetworld_2018_1500_1505 crossref_primary_10_3390_ijms25020767 crossref_primary_10_1016_j_coph_2011_01_006 crossref_primary_10_1016_j_thromres_2019_07_023 crossref_primary_10_1071_RD17384 crossref_primary_10_1371_journal_pone_0151802 crossref_primary_10_1016_j_bjane_2021_02_029 crossref_primary_10_1152_ajpgi_00215_2017 crossref_primary_10_1038_srep05945 crossref_primary_10_3389_fnins_2019_00032 crossref_primary_10_1016_j_rvsc_2018_02_012 crossref_primary_10_1093_humrep_deab106 crossref_primary_10_1016_j_livsci_2012_05_010 crossref_primary_10_1016_j_jneuroim_2015_04_002 crossref_primary_10_1074_jbc_M706367200 crossref_primary_10_1007_s11030_023_10698_4 crossref_primary_10_1038_s41594_018_0026_8 crossref_primary_10_1097_j_pain_0000000000003124 crossref_primary_10_1074_jbc_M116_736983 crossref_primary_10_1161_JAHA_116_005465 crossref_primary_10_31083_j_jin2105148 crossref_primary_10_1021_cn300114a crossref_primary_10_1371_journal_pone_0018252 crossref_primary_10_1152_ajpgi_00354_2007 crossref_primary_10_3389_falgy_2024_1385168 crossref_primary_10_1124_jpet_108_136226 crossref_primary_10_1038_s42255_023_00839_2 crossref_primary_10_1248_bpb_b18_00975 crossref_primary_10_3390_ijms252211940 crossref_primary_10_17816_JOWD112611 crossref_primary_10_5482_HAMO_14_11_0073 crossref_primary_10_1093_lifemeta_loae039 crossref_primary_10_1371_journal_pone_0049069 crossref_primary_10_3390_biom13050800 crossref_primary_10_1016_j_mehy_2015_07_023 crossref_primary_10_1016_j_neuint_2014_01_005 crossref_primary_10_1186_1471_2210_12_4 crossref_primary_10_3390_biomedicines11113049 crossref_primary_10_3390_ph17020167 crossref_primary_10_1016_j_ejphar_2008_06_012 crossref_primary_10_17816_JOWD340789 crossref_primary_10_1007_s11239_020_02331_0 crossref_primary_10_3390_ijms241813833 crossref_primary_10_1161_JAHA_123_029785 crossref_primary_10_1111_j_1530_0277_2009_01010_x crossref_primary_10_1016_j_jpeds_2024_114290 crossref_primary_10_4158_EP14442_OR crossref_primary_10_1016_j_jveb_2014_06_001 crossref_primary_10_1016_j_gene_2016_12_006 crossref_primary_10_1016_j_phrs_2018_10_018 crossref_primary_10_3390_app13052970 crossref_primary_10_1016_j_phrs_2018_06_015 crossref_primary_10_1113_EP088919 crossref_primary_10_1007_s00441_011_1256_9 crossref_primary_10_1073_pnas_1416675112 crossref_primary_10_1016_j_envres_2019_108807 crossref_primary_10_1186_1742_2094_7_10 crossref_primary_10_1016_j_jvc_2010_06_002 crossref_primary_10_1152_japplphysiol_00221_2021 crossref_primary_10_1186_s12576_022_00852_2 crossref_primary_10_1016_j_phrs_2018_10_022 crossref_primary_10_1124_pr_108_000869 crossref_primary_10_1152_ajplung_00420_2012 crossref_primary_10_1038_s41577_023_00949_8 crossref_primary_10_1371_journal_pone_0004730 crossref_primary_10_1161_HYPERTENSIONAHA_114_05061 crossref_primary_10_2478_ams_2013_0010 crossref_primary_10_3390_ijms21228705 crossref_primary_10_1039_D2MD00243D crossref_primary_10_4103_hm_hm_16_17 crossref_primary_10_1016_j_cca_2010_10_024 crossref_primary_10_4103_0366_6999_213966 crossref_primary_10_1111_j_1440_1681_2009_05147_x crossref_primary_10_1152_ajpheart_00538_2016 crossref_primary_10_1111_j_1440_1681_2011_05504_x crossref_primary_10_1152_japplphysiol_00602_2015 crossref_primary_10_1111_j_1440_1681_2008_05077_x crossref_primary_10_1002_bmc_4135 crossref_primary_10_3233_JHD_180318 crossref_primary_10_1242_jeb_244064 crossref_primary_10_1002_asia_202400544 crossref_primary_10_14814_phy2_14297 crossref_primary_10_3390_ijms21228817 crossref_primary_10_1186_s13550_021_00823_5 crossref_primary_10_3390_molecules28155846 crossref_primary_10_1038_s12276_018_0193_z crossref_primary_10_1007_s10517_014_2583_0 crossref_primary_10_1016_j_placenta_2016_03_013 crossref_primary_10_1093_braincomms_fcaf005 crossref_primary_10_3389_fcell_2023_1184550 crossref_primary_10_1016_j_jevs_2020_102969 crossref_primary_10_1016_j_bios_2024_116743 crossref_primary_10_29328_journal_jhcr_1001004 crossref_primary_10_1074_jbc_M112_345058 crossref_primary_10_1038_srep30059 crossref_primary_10_1074_jbc_M116_713693 crossref_primary_10_1124_jpet_107_135699 crossref_primary_10_4236_health_2013_54A005 crossref_primary_10_1002_bmc_3192 crossref_primary_10_1371_journal_pone_0031617 crossref_primary_10_1111_j_1755_5922_2010_00173_x crossref_primary_10_1124_pr_111_004697 crossref_primary_10_1016_j_bbr_2021_113353 crossref_primary_10_1038_srep22747 crossref_primary_10_1111_gbb_12084 crossref_primary_10_3389_fphys_2016_00042 crossref_primary_10_1016_j_jphs_2021_01_007 crossref_primary_10_1016_j_yjmcc_2012_02_004 crossref_primary_10_1152_classicessays_zh4_8503_2008 crossref_primary_10_1016_j_freeradbiomed_2016_11_023 crossref_primary_10_3389_fphys_2019_00932 crossref_primary_10_1002_hup_2818 crossref_primary_10_1096_fj_07_100743 crossref_primary_10_1016_j_jveb_2012_06_003 crossref_primary_10_1002_jemt_22214 crossref_primary_10_1016_j_aca_2021_338803 crossref_primary_10_1002_npr2_12194 crossref_primary_10_1016_j_pdpdt_2021_102342 crossref_primary_10_1152_ajpregu_90676_2008 crossref_primary_10_1097_MD_0000000000004849 crossref_primary_10_1038_s41386_018_0133_6 crossref_primary_10_3390_s20020423 crossref_primary_10_1007_s10522_012_9406_3 |
| Cites_doi | 10.1038/354066a0 10.1016/0003-4975(96)00674-1 10.1093/ajh/1.3.324S 10.1161/hc0902.104708 10.1016/0014-2999(87)90282-2 10.1097/00005344-200007000-00008 10.1006/phrs.2001.0817 10.1056/NEJM199103073241001 10.1517/14656566.2.11.1725 10.1124/mol.53.4.649 10.1016/S0024-3205(97)01166-1 10.1046/j.1471-4159.2003.01793.x 10.1016/0165-1781(90)90031-Y 10.1016/0024-3205(94)00735-7 10.1073/pnas.76.9.4350 10.1111/j.1440-1681.2006.04410.x 10.1073/pnas.90.6.2542 10.1016/S0896-6273(03)00605-6 10.1067/mhj.2003.91 10.1016/0024-3205(73)90061-1 10.1073/pnas.97.7.3106 10.1172/JCI8944 10.1046/j.1471-4159.1996.66062621.x 10.1126/science.285.5428.763 10.1016/j.mce.2004.07.017 10.1111/j.1471-4159.1993.tb03522.x 10.1042/CS20040364 10.1161/01.CIR.0000145613.01188.0B 10.1074/jbc.M306360200 10.1016/S0021-9258(20)80587-0 10.1074/jbc.274.2.889 10.1126/science.274.5292.1527 10.1126/science.1948036 10.1016/0006-3223(94)90641-6 10.1161/01.HYP.0000077901.84467.E1 10.1074/jbc.M408154200 10.1182/blood.V64.1.185.185 10.1046/j.1538-7836.2003.00474.x 10.1016/j.ejphar.2003.08.065 10.1124/mol.64.2.440 10.1523/JNEUROSCI.19-23-10193.1999 10.1016/0167-5273(92)90031-W 10.1016/0049-3848(95)91609-O 10.1161/01.HYP.8.2.167 |
| ContentType | Journal Article |
| Copyright | 2007 INIST-CNRS 2007 The Authors Journal compilation 2007 International Society for Neurochemistry 2007 The Authors Journal Compilation © 2007 International Society for Neurochemistry 2007 |
| Copyright_xml | – notice: 2007 INIST-CNRS – notice: 2007 The Authors Journal compilation 2007 International Society for Neurochemistry – notice: 2007 The Authors Journal Compilation © 2007 International Society for Neurochemistry 2007 |
| DBID | FBQ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7S9 L.6 7X8 5PM |
| DOI | 10.1111/j.1471-4159.2007.04542.x |
| DatabaseName | AGRIS CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Chemoreception Abstracts Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Chemoreception Abstracts Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | CrossRef Neurosciences Abstracts MEDLINE - Academic Virology and AIDS Abstracts AGRICOLA MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology Chemistry |
| EISSN | 1471-4159 |
| EndPage | 215 |
| ExternalDocumentID | PMC3041643 1287483161 17506858 18837878 10_1111_j_1471_4159_2007_04542_x JNC4542 US201300783357 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL091196 |
| GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29L 2WC 31~ 33P 36B 3SF 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJUZ AANLZ AAONW AASGY AAVGM AAXRX AAYJJ AAZKR ABCQN ABCUV ABCVL ABEML ABHUG ABIVO ABLJU ABPTK ABPVW ABQWH ABWRO ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACGOF ACIWK ACMXC ACNCT ACPOU ACPRK ACSCC ACSMX ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHEFC AI. AIACR AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FBQ FEDTE FIJ FUBAC FZ0 G-S G.N GAKWD GODZA GX1 H.X HF~ HH5 HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TWZ UB1 V8K VH1 W8V W99 WBKPD WIH WIJ WIK WIN WNSPC WOHZO WOW WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XJT YFH YNH YOC YUY ZA5 ZGI ZXP ZZTAW ~IA ~KM ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ AHBTC AITYG ALVPJ HGLYW OIG AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM 7QR 7TK 7U7 7U9 8FD C1K FR3 H94 P64 7S9 L.6 7X8 5PM |
| ID | FETCH-LOGICAL-c6312-f963eefbe4099cbc53ebf004618493416480e00771915b7fe28704bd9410a4353 |
| IEDL.DBID | DR2 |
| ISSN | 0022-3042 |
| IngestDate | Thu Aug 21 14:06:43 EDT 2025 Fri Jul 11 04:51:39 EDT 2025 Fri Jul 11 11:01:58 EDT 2025 Fri Jul 11 06:39:52 EDT 2025 Fri Jul 25 19:42:47 EDT 2025 Fri May 30 11:00:26 EDT 2025 Mon Jul 21 09:14:27 EDT 2025 Thu Apr 24 22:55:54 EDT 2025 Tue Jul 01 01:22:54 EDT 2025 Wed Jan 22 16:23:52 EST 2025 Wed Dec 27 19:17:29 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Hypertension Serotonin Vasoconstriction Cardiovascular disease platelet serotonin uptake Uptake Blood Vasomotricity Chronic Platelet Serotonin transporter Plasma membrane Neurotransmitter Models plasma serotonin level Biological receptor |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6312-f963eefbe4099cbc53ebf004618493416480e00771915b7fe28704bd9410a4353 |
| Notes | http://dx.doi.org/10.1111/j.1471-4159.2007.04542.x ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| PMID | 17506858 |
| PQID | 206550885 |
| PQPubID | 31528 |
| PageCount | 10 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3041643 proquest_miscellaneous_70613674 proquest_miscellaneous_47355511 proquest_miscellaneous_20433713 proquest_journals_206550885 pubmed_primary_17506858 pascalfrancis_primary_18837878 crossref_primary_10_1111_j_1471_4159_2007_04542_x crossref_citationtrail_10_1111_j_1471_4159_2007_04542_x wiley_primary_10_1111_j_1471_4159_2007_04542_x_JNC4542 fao_agris_US201300783357 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | July 2007 |
| PublicationDateYYYYMMDD | 2007-07-01 |
| PublicationDate_xml | – month: 07 year: 2007 text: July 2007 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England – name: New York |
| PublicationTitle | Journal of neurochemistry |
| PublicationTitleAlternate | J Neurochem |
| PublicationYear | 2007 |
| Publisher | Oxford, UK : Blackwell Publishing Ltd Blackwell Publishing Ltd Blackwell |
| Publisher_xml | – name: Oxford, UK : Blackwell Publishing Ltd – name: Blackwell Publishing Ltd – name: Blackwell |
| References | 1990; 32 1984; 64 1987; 140 2004; 226 1990; 33 1991; 354 1991; 254 2003; 479 1993; 60 2002; 5 1973; 15 2004; 26 1995; 77 1999; 285 2006; 3 1998; 62 1999; 104 2003; 278 1992; 34 1979; 76 2001; 43 1988; 1 1996; 29 2004; 279 2000; 36 1986; 8 1999; 19 1952; 105 1995; 22 2000; 97 1999; 274 1993a; 268 1994; 55 2005; 108 1994; 36 1996; 62 2001; 2 2003; 1 2003; 40 1993b; 90 1998; 53 1991; 324 2003; 85 2003; 145 2003; 42 2003; 64 1989 1996; 66 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 Wocial B. (e_1_2_7_48_1) 1990; 33 e_1_2_7_18_1 Freyburger W. A. (e_1_2_7_14_1) 1952; 105 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_47_1 e_1_2_7_27_1 e_1_2_7_49_1 e_1_2_7_28_1 e_1_2_7_29_1 Willerson J. T. (e_1_2_7_46_1) 1995; 22 Ramamoorthy S. (e_1_2_7_35_1) 1993; 268 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 Shulman N. B. (e_1_2_7_40_1) 1989 e_1_2_7_20_1 Lesch K. P. (e_1_2_7_26_1) 1996; 29 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 J Neurochem. 2008 Oct;107(1):302 |
| References_xml | – volume: 36 start-page: 56 year: 2000 end-page: 64 article-title: Platelet activation is increased in cyclosporin A‐induced hypertensive rats publication-title: J. Cardiovasc. Pharmacol. – volume: 66 start-page: 2621 year: 1996 end-page: 2624 article-title: Allelic variation of human serotonin transporter gene expression publication-title: J. Neurochem. – volume: 140 start-page: 259 year: 1987 end-page: 266 article-title: Comparison of effects of some 5‐HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats publication-title: Eur. J. Pharmacol. – volume: 274 start-page: 889 year: 1999 end-page: 895 article-title: Regulation of gamma‐aminobutyric acid (GABA) transporters by exogenous GABA publication-title: J. Biol. Chem. – volume: 104 start-page: 1663 year: 1999 end-page: 1665 article-title: More pieces of the platelet activation puzzle slide into place publication-title: J. Clin. Invest. – start-page: 180 year: 1989 end-page: 193 article-title: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow‐up program. The Hypertension Detection and Follow‐up Program Cooperative Group publication-title: Hypertension – volume: 64 start-page: 185 year: 1984 end-page: 193 article-title: Heterogeneity of human whole blood platelet subpopulations. III. Density‐dependent differences in subcellular constituents publication-title: Blood – volume: 26 start-page: 2701 year: 2004 end-page: 2707 article-title: Intravascular thrombosis after hypoxia‐induced pulmonary hypertension: regulation by cyclooxygenase‐2 publication-title: Circulation – volume: 268 start-page: 21626 year: 1993a end-page: 21631 article-title: Regulation of the human serotonin transporter. Cholera toxin‐induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter‐specific ligand binding publication-title: J. Biol. Chem. – volume: 64 start-page: 4 year: 2003 end-page: 12 article-title: A Human 5HT Transporter Mutation Causes Constitutive Activation of Transport Activity. (A Human 5HT Transporter Mutation Causes Constitutive Activation of Transport Activity publication-title: Mol. Pharmacol. – volume: 285 start-page: 763 year: 1999 end-page: 766 article-title: Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants publication-title: Science – volume: 279 start-page: 47254 year: 2004 end-page: 47263 article-title: Pharmacochaperones post‐translationally enhance cell surface expression by increasing conformational stability of wild‐type and mutant vasopressin V2 receptors publication-title: J. Biol. Chem. – volume: 43 start-page: 453 year: 2001 end-page: 461 article-title: Platelet inhibition by sertraline and N‐desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors publication-title: Pharmacol. Res. – volume: 32 start-page: 265 year: 1990 end-page: 273 article-title: 3H‐imipramine binding in the blood platelets of normal twins publication-title: Psychiatry Res. – volume: 55 start-page: 327 year: 1994 end-page: 335 article-title: Relevance of platelet serotonergic mechanisms in pregnancy induced hypertension publication-title: Life Sci. – volume: 254 start-page: 579 year: 1991 end-page: 580 article-title: Cloning of the 5HT transporter affected by antidepressants publication-title: Science – volume: 76 start-page: 4350 year: 1979 end-page: 4354 article-title: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications publication-title: Proc. Natl. Acad. Sci. USA – volume: 62 start-page: 1723 year: 1998 end-page: 1732 article-title: Serotonin and vasoconstrictor synergism publication-title: Life Sci. – volume: 33 start-page: 4 year: 1990 end-page: 7 article-title: Free serotonin level in the blood of patients with borderline and essential hypertension publication-title: Kardiol. Pol. – volume: 53 start-page: 649 year: 1998 end-page: 655 article-title: Altered brain serotonin homeostasis and locomotor insensitivity to 3,4‐methylenedioxymethamphetamine (“Ecstasy”) in serotonin transporter‐deficient mice publication-title: Mol. Pharmacol. – volume: 29 start-page: 1527 year: 1996 end-page: 1531 article-title: Association of anxiety‐related traits with a polymorphism in the serotonin transporter gene regulatory region publication-title: Science – volume: 40 start-page: 537 year: 2003 end-page: 549 article-title: Regulating the conducting states of a mammalian serotonin transporter publication-title: Neuron – volume: 354 start-page: 66 year: 1991 end-page: 70 article-title: Cloning and expression of a functional the 5HT transporter from rat brain publication-title: Nature – volume: 42 start-page: 1 year: 2003 end-page: 7 article-title: Pharmacological modulation of platelet function in hypertension publication-title: Hypertension – volume: 2 start-page: 1725 year: 2001 end-page: 1736 article-title: Pharmacotherapy of intermittent claudication publication-title: Expert Opin. Pharmacother. – volume: 1 start-page: 2663 year: 2003 end-page: 2668 article-title: The effect of the anorectic agent, d‐fenfluramine, and its primary metabolite, d‐norfenfluramine, on intact human platelet serotonin uptake and efflux publication-title: J. Thromb. Haemost. – volume: 60 start-page: 2319 year: 1993 end-page: 2322 article-title: Primary structure of the human platelet 5HT uptake site: identity with the brain 5HT transporter publication-title: J. Neurochem. – volume: 19 start-page: 10193 year: 1999 end-page: 10200 article-title: Glutamate induces rapid upregulation of astrocyte glutamate transport and cell‐surface expression of GLAST publication-title: J. Neurosci. – volume: 105 start-page: 80 year: 1952 end-page: 86 article-title: The pharmacology of 5‐hydroxytryptamine (serotonin) publication-title: J. Pharmacol. Exp. Ther. – volume: 90 start-page: 2542 year: 1993b end-page: 2546 article-title: Antidepressant‐ and cocaine‐sensitive human the 5HT transporter: molecular cloning, expression, and chromosomal localization publication-title: Proc. Natl. Acad. Sci. USA – volume: 5 start-page: 1082 year: 2002 end-page: 1087 article-title: Risk and predictors of stroke after myocardial infarction among the elderly: results from the Cooperative Cardiovascular Project publication-title: Circulation – volume: 145 start-page: 676 year: 2003 end-page: 682 article-title: Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation publication-title: Am. Heart J. – volume: 3 start-page: 575 year: 2006 end-page: 583 article-title: 5‐hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT) publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 108 start-page: 399 year: 2005 end-page: 412 article-title: 5‐HT in systemic hypertension publication-title: Clin. Sci. – volume: 85 start-page: 1513 year: 2003 end-page: 1520 article-title: Functional consequences of Homo‐ But Not Hetero‐Oligomerization between transporters for the biogenic amine neurotransmitters publication-title: J. Neurochem. – volume: 226 start-page: 33 year: 2004 end-page: 42 article-title: Intracellular signaling involved in estrogen regulation of serotonin reuptake publication-title: Mol. Cell Endocrinol. – volume: 36 start-page: 458 year: 1994 end-page: 466 article-title: Platelet [3H]paroxetine binding, 5‐HT‐stimulated Ca2+ response, and 5‐HT content in winter seasonal affective disorder publication-title: Biol. Psychiatry – volume: 22 start-page: 13 year: 1995 end-page: 19 article-title: Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products publication-title: Tex Heart Inst. J. – volume: 278 start-page: 43991 year: 2003 end-page: 44000 article-title: Glycosyl Modification Facilitates Homo‐ and Hetero‐Oligomerization of Serotonin Transporter. A Specific Role for the Sialic Acid Residues publication-title: J. Biol. Chem. – volume: 77 start-page: 217 year: 1995 end-page: 224 article-title: Serotonin is involved in the pathogenesis of hypertension developing during erythropoietin treatment in uremic rats publication-title: Thromb. Res. – volume: 1 start-page: 324S year: 1988 end-page: 330S article-title: Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension publication-title: Am. J. Hypertens. – volume: 324 start-page: 641 year: 1991 end-page: 648 article-title: Divergent effects of serotonin on coronary‐artery dimensions and blood flow in patients with coronary atherosclerosis and control patients publication-title: New Engl. J. Med. – volume: 479 start-page: 153 year: 2003 end-page: 158 article-title: Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine publication-title: Eur. J. Pharmacol. – volume: 97 start-page: 3106 year: 2000 end-page: 3111 article-title: Oligomerization of 5HT transporter and its functional consequences publication-title: Proc. Natl. Acad. Sci. USA – volume: 34 start-page: 327 year: 1992 end-page: 333 article-title: Factors influencing platelet serotonin uptake in essential hypertension publication-title: Int. J. Cardiol. – volume: 15 start-page: 49 year: 1973 end-page: 62 article-title: Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents publication-title: Life Sci. I. – volume: 62 start-page: 1392 year: 1996 end-page: 1396 article-title: Hypertension increases the contractions to sumatriptan in the human internal mammary artery publication-title: Ann. Thorac. Surg. – volume: 8 start-page: 167 year: 1986 end-page: 173 article-title: Chronic effect of ketanserin in mild to moderate essential hypertension publication-title: Hypertension – ident: e_1_2_7_6_1 doi: 10.1038/354066a0 – ident: e_1_2_7_43_1 doi: 10.1016/0003-4975(96)00674-1 – ident: e_1_2_7_13_1 doi: 10.1093/ajh/1.3.324S – ident: e_1_2_7_28_1 doi: 10.1161/hc0902.104708 – ident: e_1_2_7_10_1 doi: 10.1016/0014-2999(87)90282-2 – ident: e_1_2_7_38_1 doi: 10.1097/00005344-200007000-00008 – ident: e_1_2_7_39_1 doi: 10.1006/phrs.2001.0817 – ident: e_1_2_7_15_1 doi: 10.1056/NEJM199103073241001 – ident: e_1_2_7_11_1 doi: 10.1517/14656566.2.11.1725 – ident: e_1_2_7_4_1 doi: 10.1124/mol.53.4.649 – ident: e_1_2_7_44_1 doi: 10.1016/S0024-3205(97)01166-1 – ident: e_1_2_7_24_1 doi: 10.1046/j.1471-4159.2003.01793.x – start-page: 180 year: 1989 ident: e_1_2_7_40_1 article-title: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow‐up program. The Hypertension Detection and Follow‐up Program Cooperative Group publication-title: Hypertension – ident: e_1_2_7_2_1 doi: 10.1016/0165-1781(90)90031-Y – ident: e_1_2_7_16_1 doi: 10.1016/0024-3205(94)00735-7 – ident: e_1_2_7_42_1 doi: 10.1073/pnas.76.9.4350 – volume: 22 start-page: 13 year: 1995 ident: e_1_2_7_46_1 article-title: Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products publication-title: Tex Heart Inst. J. – ident: e_1_2_7_29_1 doi: 10.1111/j.1440-1681.2006.04410.x – ident: e_1_2_7_36_1 doi: 10.1073/pnas.90.6.2542 – ident: e_1_2_7_34_1 doi: 10.1016/S0896-6273(03)00605-6 – ident: e_1_2_7_41_1 doi: 10.1067/mhj.2003.91 – ident: e_1_2_7_32_1 doi: 10.1016/0024-3205(73)90061-1 – ident: e_1_2_7_23_1 doi: 10.1073/pnas.97.7.3106 – ident: e_1_2_7_8_1 doi: 10.1172/JCI8944 – volume: 105 start-page: 80 year: 1952 ident: e_1_2_7_14_1 article-title: The pharmacology of 5‐hydroxytryptamine (serotonin) publication-title: J. Pharmacol. Exp. Ther. – ident: e_1_2_7_17_1 doi: 10.1046/j.1471-4159.1996.66062621.x – ident: e_1_2_7_37_1 doi: 10.1126/science.285.5428.763 – ident: e_1_2_7_25_1 doi: 10.1016/j.mce.2004.07.017 – ident: e_1_2_7_27_1 doi: 10.1111/j.1471-4159.1993.tb03522.x – ident: e_1_2_7_45_1 doi: 10.1042/CS20040364 – ident: e_1_2_7_33_1 doi: 10.1161/01.CIR.0000145613.01188.0B – ident: e_1_2_7_31_1 doi: 10.1074/jbc.M306360200 – volume: 268 start-page: 21626 year: 1993 ident: e_1_2_7_35_1 article-title: Regulation of the human serotonin transporter. Cholera toxin‐induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter‐specific ligand binding publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(20)80587-0 – ident: e_1_2_7_5_1 doi: 10.1074/jbc.274.2.889 – volume: 33 start-page: 4 year: 1990 ident: e_1_2_7_48_1 article-title: Free serotonin level in the blood of patients with borderline and essential hypertension publication-title: Kardiol. Pol. – volume: 29 start-page: 1527 year: 1996 ident: e_1_2_7_26_1 article-title: Association of anxiety‐related traits with a polymorphism in the serotonin transporter gene regulatory region publication-title: Science doi: 10.1126/science.274.5292.1527 – ident: e_1_2_7_18_1 doi: 10.1126/science.1948036 – ident: e_1_2_7_30_1 doi: 10.1016/0006-3223(94)90641-6 – ident: e_1_2_7_7_1 doi: 10.1161/01.HYP.0000077901.84467.E1 – ident: e_1_2_7_49_1 doi: 10.1074/jbc.M408154200 – ident: e_1_2_7_9_1 doi: 10.1182/blood.V64.1.185.185 – ident: e_1_2_7_20_1 doi: 10.1046/j.1538-7836.2003.00474.x – ident: e_1_2_7_21_1 doi: 10.1016/j.ejphar.2003.08.065 – ident: e_1_2_7_22_1 doi: 10.1124/mol.64.2.440 – ident: e_1_2_7_12_1 doi: 10.1523/JNEUROSCI.19-23-10193.1999 – ident: e_1_2_7_19_1 doi: 10.1016/0167-5273(92)90031-W – ident: e_1_2_7_3_1 doi: 10.1016/0049-3848(95)91609-O – ident: e_1_2_7_47_1 doi: 10.1161/01.HYP.8.2.167 – reference: - J Neurochem. 2008 Oct;107(1):302 |
| SSID | ssj0016461 |
| Score | 2.3230379 |
| Snippet | Serotonin (5HT) is a platelet-stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including... Serotonin (5HT) is a platelet‐stored vasoconstrictor. Altered concentrations of circulating 5HT are implicated in several pathologic conditions, including... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wiley fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 206 |
| SubjectTerms | Arterial hypertension. Arterial hypotension Biological and medical sciences Biophysics biosynthesis Biotin blood Blood and lymphatic vessels Blood Platelets Blood Platelets - metabolism Blood pressure Blotting, Western Cardiology. Vascular system Cell Membrane Cell Membrane - drug effects Cell Membrane - metabolism Cell receptors Cell structures and functions drug effects Enzyme-Linked Immunosorbent Assay Feedback Feedback - physiology Fundamental and applied biological sciences. Psychology Humans Hypertension Hypertension - blood Hypotheses Kinetics Male Medical sciences metabolism Middle Aged Molecular and cellular biology Monoamines receptors (catecholamine, serotonine, histamine, acetylcholine) Neurotransmitters physiology Plasma plasma serotonin level platelet serotonin uptake serotonin Serotonin - blood Serotonin Plasma Membrane Transport Proteins Serotonin Plasma Membrane Transport Proteins - biosynthesis Serotonin Plasma Membrane Transport Proteins - blood serotonin transporter Signal transduction |
| Title | Plasma serotonin levels and the platelet serotonin transporter |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1471-4159.2007.04542.x https://www.ncbi.nlm.nih.gov/pubmed/17506858 https://www.proquest.com/docview/206550885 https://www.proquest.com/docview/20433713 https://www.proquest.com/docview/47355511 https://www.proquest.com/docview/70613674 https://pubmed.ncbi.nlm.nih.gov/PMC3041643 |
| Volume | 102 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELagF7jwaIEuheAD4rbROn5tLkhVRFWKqBAQqTfL9tqAmm6qZiMBv56ZfTVbWqlC3CKt7XjHM-Nv7NlvCHmdC2ej81mqYx5TYT1Pc65EKjwXAEi5UBG_Rv54rA7n4uhEnrT5T_gtTMMP0R-4oWXU_hoN3LrVFSPXEP_AftwyEQopJmPEkwz-DfHR555JClm0WE8cDoo6TOq5dqDBTnU32iXmTdoViC42NS-uA6V_51ZuYt560zp4SE67121yVU7H68qN_e8rTJD_Rx6PyIMW29L9Rhkfkzuh3CY7-yXE9We_6BtaZ5vWx_jb5N6sqzS3Q95-Agh_ZilYw7LC42G6wFSmFbVlQQGg0vMFIGJQsI0WVU_KfvGEzA_efZ0dpm1dh9QrziZpBKMPIboAseXUOy95cBEDdYg2QTtgrfIsIM8QxJLS6RjwMla4YipYZgHe8adkq1yWYZdQKwolsiIqGeFlbQQ0FSTXWaG991ORJ0R3a2h8S3qOtTcWZjP40cyg2LAkpza12MzPhLC-53lD_HGLPrugJsZ-A_9s5l8meCuM16Rc6oSMBrpzOWaOlP4aZrrXKZNp3cgKBlcSEbRMyKv-KSwOXurYMizX2ERwrhm_uQUWlwZczG5uoRHUKS0S8qxR3svZAaDECgUgx4Fa9w2QnXz4pPzxvWYpByuDlYR5qVprby1Ec3Q8w1_P_7XjHrnfHcBn7AXZqi7W4SUgx8qNwCe8_zCqPcMfAdpdFw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BOZQLjxZoKLQ5IG5ZJWvHzl6QqhXVUtoVgq7Um-U4NiC22aqblYBfz4zz6Ka0UoW4RYptOeMZ-5vx5BuANxnPtctNHEmXuYhrw6KMCR5xwzgCUsaFo7-RT6ZiMuNHZ-lZUw6I_oWp-SG6gBtZht-vycApIH3NyiU6QHggN1SEPOXDAQLKB_66jhDS545Lini0ko46HFW1n9Zz40i9s-q-0wvKnNRLFJ6rq17cBEv_zq5cR73-2Dp8DPP2g-tslR-DVZUPzO9rXJD_SSJP4FEDb8ODWh-fwj1bbsH2QYmu_fmv8G3oE059JH8LNsdtsbltePcJUfy5DtEgFhVFiMM5ZTMtQ10WIWLU8GKOoBh1bK1F1fGyXz6D2eH70_Ekako7REawZBg5tHtrXW7RvRyZ3KTM5o58dXQ4UUFwsbLYEtUQupNpLp2l-1ieFyOexBoRHnsOG-WitDsQal4IHhdOpA4_VjsEVDZlMi6kMWbEswBku4jKNLznVH5jrtb9H5koEhtV5ZTKi039DCDpel7U3B936LODeqL0V9yi1ezLkC6G6aaUpTKAvZ7yXI2ZEau_xJnuttqkmp1kiYOLlEB0GsB-9xYXh-51dGkXK2rCGZMJu70F1ZdGaJzc3kISrhOSB_Ci1t6r2SGmpCIFKMeeXncNiKC8_6b8_s0TlaOZ4UrivIRX2zsLUR1Nx_T08l877sPm5PTkWB1_mH7chYdtPD5OXsFGdbmyrxFIVvme3yD-AJItYDw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED_BkGAvfGywhY0tD4i3VEnt2OkL0tStGgOqCai0N8txbEDr0mpNJeCv5y5fa_YhTYi3SDlbzvnO_p19-R3A24Sn2qUmDKRLXMC1YUHCBA-4YRwBKePC0d_In8fieMJPzuKzOv-J_oWp-CHaAzfyjHK9JgefZ-6ak0uMf3A_rpkIecz7PcSTj7jAXZMA0peWSopotKKWORwttZvVc2tPna3qodMzSpzUC9Sdq4pe3IZKbyZXroLectcaPYPz5nurZJXz3rJIe-bPNSrI_6OQ5_C0Brf-QWWNL-CBzTdg8yDHwP7it__OL9NNy3P8DXgybErNbcL7U8TwF9pHd5gVdD7sTymXaeHrPPMRofrzKUJitLAViaJlZb98CZPR0bfhcVAXdgiMYFE_cOj11rrUYnA5MKmJmU0dReoYbqJ54FwloSWiIQwm41Q6S7exPM0GPAo14jv2CtbyWW63wdc8EzzMnIgdfqx2CKdszGSYSWPMgCceyGYOlalZz6n4xlStRj8yUqQ2qskpVak29cuDqG05r5g_7tFmG81E6e-4QKvJ1z5dC9M9KYulB3sd27nqMyFOf4kj3WmMSdXryAI7FzFB6NiD_fYtTg7d6ujczpYkwhmTEbtbgqpLIzCO7paQhOqE5B5sVcZ7NTpElFSiAPXYMetWgOjJu2_ynz9KmnL0MpxJHJcorfbeSlQn4yE9vf7Xhvvw-PRwpD59GH_cgfXmMD6MdmGtuFzaN4gii3SvXB7-AguPXus |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+serotonin+levels+and+the+platelet+serotonin+transporter&rft.jtitle=Journal+of+neurochemistry&rft.au=Brenner%2C+B.&rft.au=Harney%2C+J.+T.&rft.au=Ahmed%2C+B.+A.&rft.au=Jeffus%2C+B.+C.&rft.date=2007-07-01&rft.issn=0022-3042&rft.eissn=1471-4159&rft.volume=102&rft.issue=1&rft.spage=206&rft.epage=215&rft_id=info:doi/10.1111%2Fj.1471-4159.2007.04542.x&rft_id=info%3Apmid%2F17506858&rft.externalDocID=PMC3041643 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3042&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3042&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3042&client=summon |